Literature DB >> 21330373

Glutaminyl cyclase knock-out mice exhibit slight hypothyroidism but no hypogonadism: implications for enzyme function and drug development.

Stephan Schilling1, Stephanie Kohlmann, Christoph Bäuscher, Reinhard Sedlmeier, Birgit Koch, Rico Eichentopf, Andreas Becker, Holger Cynis, Torsten Hoffmann, Sabine Berg, Ernst-Joachim Freyse, Stephan von Hörsten, Steffen Rossner, Sigrid Graubner, Hans-Ulrich Demuth.   

Abstract

Glutaminyl cyclases (QCs) catalyze the formation of pyroglutamate (pGlu) residues at the N terminus of peptides and proteins. Hypothalamic pGlu hormones, such as thyrotropin-releasing hormone and gonadotropin-releasing hormone are essential for regulation of metabolism and fertility in the hypothalamic pituitary thyroid and gonadal axes, respectively. Here, we analyzed the consequences of constitutive genetic QC ablation on endocrine functions and on the behavior of adult mice. Adult homozygous QC knock-out mice are fertile and behave indistinguishably from wild type mice in tests of motor function, cognition, general activity, and ingestion behavior. The QC knock-out results in a dramatic drop of enzyme activity in the brain, especially in hypothalamus and in plasma. Other peripheral organs like liver and spleen still contain QC activity, which is most likely caused by its homolog isoQC. The serum gonadotropin-releasing hormone, TSH, and testosterone concentrations were not changed by QC depletion. The serum thyroxine was decreased by 24% in homozygous QC knock-out animals, suggesting a mild hypothyroidism. QC knock-out mice were indistinguishable from wild type with regard to blood glucose and glucose tolerance, thus differing from reports of thyrotropin-releasing hormone knock-out mice significantly. The results suggest a significant formation of the hypothalamic pGlu hormones by alternative mechanisms, like spontaneous cyclization or conversion by isoQC. The different effects of QC depletion on the hypothalamic pituitary thyroid and gonadal axes might indicate slightly different modes of substrate conversion of both enzymes. The absence of significant abnormalities in QC knock-out mice suggests the presence of a therapeutic window for suppression of QC activity in current drug development.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21330373      PMCID: PMC3077621          DOI: 10.1074/jbc.M111.229385

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  40 in total

1.  The RESID database of protein structure modifications: 2000 update.

Authors:  J S Garavelli
Journal:  Nucleic Acids Res       Date:  2000-01-01       Impact factor: 16.971

2.  Forces and structural limitations of binding of thyrotrophin-releasing factor to the thyrotrophin-releasing receptor: the pyroglutamic acid moiety.

Authors:  H J Goren; L G Bauce; W Vale
Journal:  Mol Pharmacol       Date:  1977-07       Impact factor: 4.436

Review 3.  Gonadotropin-releasing hormone analog design. Structure-function studies toward the development of agonists and antagonists: rationale and perspective.

Authors:  M J Karten; J E Rivier
Journal:  Endocr Rev       Date:  1986-02       Impact factor: 19.871

4.  Rat progastrin processing yields peptides with altered potency at the CCK-B receptor.

Authors:  David A Keire; S Vincent Wu; David L Diehl; Peter Chew; Fang-Jen Ho; Michael T Davis; Terry D Lee; John E Shively; John H Walsh; Joseph R Reeve
Journal:  Regul Pept       Date:  2003-05-15

5.  Luteinizing hormone-releasing hormone analogs lacking N-terminal pGlu ring structure.

Authors:  Y Okada; K Kitamura; Y Baba; A Arimura; A V Schally
Journal:  Biochem Biophys Res Commun       Date:  1973-08-21       Impact factor: 3.575

6.  Primary structure of human plasma fibronectin. The 29,000-dalton NH2-terminal domain.

Authors:  A Garcia-Pardo; E Pearlstein; B Frangione
Journal:  J Biol Chem       Date:  1983-10-25       Impact factor: 5.157

7.  A deletion truncating the gonadotropin-releasing hormone gene is responsible for hypogonadism in the hpg mouse.

Authors:  A J Mason; J S Hayflick; R T Zoeller; W S Young; H S Phillips; K Nikolics; P H Seeburg
Journal:  Science       Date:  1986-12-12       Impact factor: 47.728

Review 8.  Pyroglutamic acid. Non-metabolic formation, function in proteins and peptides, and characteristics of the enzymes effecting its removal.

Authors:  G N Abraham; D N Podell
Journal:  Mol Cell Biochem       Date:  1981-08-11       Impact factor: 3.396

9.  Pyroglutamate formation influences solubility and amyloidogenicity of amyloid peptides.

Authors:  Dagmar Schlenzig; Susanne Manhart; Yeliz Cinar; Martin Kleinschmidt; Gerd Hause; Dieter Willbold; Susanne Aileen Funke; Stephan Schilling; Hans-Ulrich Demuth
Journal:  Biochemistry       Date:  2009-07-28       Impact factor: 3.162

Review 10.  Mice lacking the thyrotropin-releasing hormone gene: what do they tell us?

Authors:  Masanobu Yamada; Tetsurou Satoh; Masatomo Mori
Journal:  Thyroid       Date:  2003-12       Impact factor: 6.568

View more
  10 in total

1.  The prohormone proenkephalin possesses differential conformational features of subdomains revealed by rapid H-D exchange mass spectrometry.

Authors:  Weiya D Lu; Tong Liu; Sheng Li; Virgil L Woods; Vivian Hook
Journal:  Protein Sci       Date:  2012-01-04       Impact factor: 6.725

Review 2.  Central regulation of hypothalamic-pituitary-thyroid axis under physiological and pathophysiological conditions.

Authors:  Csaba Fekete; Ronald M Lechan
Journal:  Endocr Rev       Date:  2013-12-13       Impact factor: 19.871

Review 3.  Pyroglutamate amyloid-β (Aβ): a hatchet man in Alzheimer disease.

Authors:  Sadim Jawhar; Oliver Wirths; Thomas A Bayer
Journal:  J Biol Chem       Date:  2011-09-29       Impact factor: 5.157

4.  2-Amino-1,3,4-thiadiazoles as Glutaminyl Cyclases Inhibitors Increase Phagocytosis through Modification of CD47-SIRPα Checkpoint.

Authors:  Eunsun Park; Kyung-Hee Song; Darong Kim; Minyoung Lee; Nguyen Van Manh; Hee Kim; Ki Bum Hong; Jeewoo Lee; Jie-Young Song; Soosung Kang
Journal:  ACS Med Chem Lett       Date:  2022-08-16       Impact factor: 4.632

5.  Glutaminyl cyclases as novel targets for the treatment of septic arthritis.

Authors:  Annelie Hellvard; Katarzyna Maresz; Stephan Schilling; Sigrid Graubner; Ulrich Heiser; Roland Jonsson; Holger Cynis; Hans-Ulrich Demuth; Jan Potempa; Piotr Mydel
Journal:  J Infect Dis       Date:  2012-11-29       Impact factor: 5.226

6.  Function of Cathepsin K in the Central Nervous System of Male Mice is Independent of Its Role in the Thyroid Gland.

Authors:  Stephanie Dauth; Helena Rakov; Ruxandra F Sîrbulescu; Iulian Ilieş; Jonas Weber; Battuja Batbajar Dugershaw; Doreen Braun; Maren Rehders; Eva K Wirth; Dagmar Führer; Ulrich Schweizer; Klaudia Brix
Journal:  Cell Mol Neurobiol       Date:  2019-12-05       Impact factor: 5.046

7.  The isoenzyme of glutaminyl cyclase is an important regulator of monocyte infiltration under inflammatory conditions.

Authors:  Holger Cynis; Torsten Hoffmann; Daniel Friedrich; Astrid Kehlen; Kathrin Gans; Martin Kleinschmidt; Jens-Ulrich Rahfeld; Raik Wolf; Michael Wermann; Anett Stephan; Monique Haegele; Reinhard Sedlmeier; Sigrid Graubner; Wolfgang Jagla; Anke Müller; Rico Eichentopf; Ulrich Heiser; Franziska Seifert; Paul H A Quax; Margreet R de Vries; Isabel Hesse; Daniela Trautwein; Ulrich Wollert; Sabine Berg; Ernst-Joachim Freyse; Stephan Schilling; Hans-Ulrich Demuth
Journal:  EMBO Mol Med       Date:  2011-07-20       Impact factor: 12.137

8.  A single transcription factor is sufficient to induce and maintain secretory cell architecture.

Authors:  Hei-Yong G Lo; Ramon U Jin; Greg Sibbel; Dengqun Liu; Anju Karki; Matthew S Joens; Blair B Madison; Bo Zhang; Valerie Blanc; James A J Fitzpatrick; Nicholas O Davidson; Stephen F Konieczny; Jason C Mills
Journal:  Genes Dev       Date:  2017-02-07       Impact factor: 11.361

9.  Immunohistochemical Evidence from APP-Transgenic Mice for Glutaminyl Cyclase as Drug Target to Diminish pE-Abeta Formation.

Authors:  Maike Hartlage-Rübsamen; Alexandra Bluhm; Anke Piechotta; Miriam Linnert; Jens-Ulrich Rahfeld; Hans-Ulrich Demuth; Inge Lues; Peer-Hendrik Kuhn; Stefan F Lichtenthaler; Steffen Roßner; Corinna Höfling
Journal:  Molecules       Date:  2018-04-17       Impact factor: 4.411

10.  Dynamic Expression of Imprinted Genes in the Developing and Postnatal Pituitary Gland.

Authors:  Valeria Scagliotti; Ruben Costa Fernandes Esse; Thea L Willis; Mark Howard; Isabella Carrus; Emily Lodge; Cynthia L Andoniadou; Marika Charalambous
Journal:  Genes (Basel)       Date:  2021-03-30       Impact factor: 4.096

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.